ArticleAnnals of translational medicine2020

Pretreatment systemic inflammation response index (SIRI) is an independent predictor of survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapy: a two-center retrospective study.

Min Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.